Journal
Sprout Health Review 2026: Same Price at Any Dose, a Prepaid-Year Discount, and the Brand Sticker Shock
Released: Last reviewed:
Short answer — August 2026
Sprout Health's homepage, read on October 15, 2026, prints flat compounded prices: tirzepatide $199 per 4 weeks, or $149 a month on a 12-month plan billed $1,788 up front; semaglutide $149 per 4 weeks, or $99 a month on a 12-month plan ($1,188 up front) — "Same price at any dose." In July 2026 we recorded these as "starting at" figures personalized in the signup funnel; the current page states them as dose-independent, which makes the row comparable. Two things to weigh: the 4-week billing cycle (thirteen charges a year, not twelve) and the up-front payment on the 12-month plans. A July 2026 third-party audit also captured Sprout's brand-name options at figures near seventeen ninety-nine for Wegovy and nineteen ninety-nine for Zepbound (not re-read) — multiples of the manufacturers' own $349 Wegovy pen and $299–$449 Zepbound prices, so brand buyers should price LillyDirect and NovoCare first.
What to confirm, and verdict
Three items in writing before payment: that the printed price is what you pay at your maintenance dose (the page says "Same price at any dose"); the refund and cancellation terms on the 12-month plans, since they are paid up front and renew until cancelled; and the pharmacy name for the standard verification. On the October 15 reads, Sprout's $199-per-4-weeks tirzepatide sits above Eden's $129 and above NexLife's $129 monthly (as of November 6, 2026), while its $149 12-month rate sits above NexLife's $119 (6-month) and $115 (12-month) plans; its $99 12-month semaglutide equals Eden's month-to-month $99. On the brand side, the earlier captures were outpriced by the manufacturers by wide margins. The one universal takeaway Sprout usefully illustrates: in 2026, no brand GLP-1 should be bought through a reseller without first pricing the maker's own channel.
Questions people ask
What does Sprout Health cost?
Sprout's homepage, read on October 15, 2026: compounded tirzepatide $199 per 4 weeks, or $149 a month on a 12-month plan billed $1,788 up front; semaglutide $149 per 4 weeks, or $99 a month on a 12-month plan ($1,188 up front). Same price at any dose; plans renew until cancelled.
Why are Sprout's brand prices so high?
July 2026 third-party captures (not re-read) listed its brand options near $1,799 (Wegovy) and $1,999 (Zepbound) — roughly four to five times the manufacturers' direct channels ($349 pen, $299–$449 vials). Whatever the reason, the practical rule it proves: always price LillyDirect/NovoCare before buying brand GLP-1s through any reseller.
Is Sprout's $99 semaglutide real?
It is printed on Sprout's homepage (October 15, 2026) as the 12-month-plan rate, paid $1,188 up front; month to month, semaglutide is $149 per 4 weeks. Sprout says the price is the same at any dose. Before paying a year up front, get the refund terms and the pharmacy name in writing.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.